PMC:7755033 / 81084-82237
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1434","span":{"begin":224,"end":236},"obj":"Chemical"},{"id":"1435","span":{"begin":281,"end":292},"obj":"Chemical"},{"id":"1436","span":{"begin":339,"end":350},"obj":"Chemical"},{"id":"1437","span":{"begin":397,"end":408},"obj":"Chemical"},{"id":"1438","span":{"begin":455,"end":466},"obj":"Chemical"},{"id":"1439","span":{"begin":514,"end":523},"obj":"Chemical"},{"id":"1440","span":{"begin":568,"end":582},"obj":"Chemical"},{"id":"1441","span":{"begin":629,"end":638},"obj":"Chemical"},{"id":"1442","span":{"begin":686,"end":698},"obj":"Chemical"},{"id":"1443","span":{"begin":748,"end":756},"obj":"Chemical"},{"id":"1444","span":{"begin":801,"end":813},"obj":"Chemical"},{"id":"1445","span":{"begin":863,"end":873},"obj":"Chemical"},{"id":"1446","span":{"begin":920,"end":927},"obj":"Chemical"},{"id":"1447","span":{"begin":978,"end":996},"obj":"Chemical"},{"id":"1448","span":{"begin":1042,"end":1052},"obj":"Chemical"},{"id":"1449","span":{"begin":1101,"end":1111},"obj":"Chemical"}],"attributes":[{"id":"A1435","pred":"tao:has_database_id","subj":"1435","obj":"MESH:D054358"},{"id":"A1436","pred":"tao:has_database_id","subj":"1436","obj":"MESH:D054358"},{"id":"A1437","pred":"tao:has_database_id","subj":"1437","obj":"MESH:D054358"},{"id":"A1438","pred":"tao:has_database_id","subj":"1438","obj":"MESH:D054358"},{"id":"A1439","pred":"tao:has_database_id","subj":"1439","obj":"MESH:C560597"},{"id":"A1442","pred":"tao:has_database_id","subj":"1442","obj":"MESH:C568582"},{"id":"A1444","pred":"tao:has_database_id","subj":"1444","obj":"MESH:D011342"},{"id":"A1445","pred":"tao:has_database_id","subj":"1445","obj":"MESH:D000069449"},{"id":"A1446","pred":"tao:has_database_id","subj":"1446","obj":"MESH:C086979"},{"id":"A1447","pred":"tao:has_database_id","subj":"1447","obj":"MESH:D006886"},{"id":"A1449","pred":"tao:has_database_id","subj":"1449","obj":"MESH:C557213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"S. No. Ligands Parameters of bioactivity score\nGPCR ligand Ion channel modulator (ICM) Kinase inhibitor (KI) Nuclear receptor ligand (NRL) Protease inhibitor (PI) Enzymeinhibitor (EI) \n \n1. Withaferin A 0.07 0.14 –0.49 0.76 0.15 0.94 \n2. Withanolide A 0.04 0.32 –0.43 0.71 0.15 0.86 \n3. Withanolide B 0.07 0.24 –0.47 0.79 0.15 0.76 \n4. Withanolide D 0.05 0.30 –0.50 0.73 0.16 1.07 \n5. Withanolide E –0.70 0.16 –0.50 0.61 0.06 0.89 \n6. Withanone 0.00 0.27 –0.38 0.71 0.12 0.78 \n7. Viscosalactone B 0.03 0.04 –0.51 0.78 0.19 0.84 \n8. Anaferine –0.08 0.17 –0.60 –0.58 –0.14 0.08 \n9. Withasomnine –0.49 –0.43 0.58 –0.10 –0.58 –0.17 \n10. Losartan 1.06 0.16 0.03 0.01 0.33 0.44 \n11. Procainamide –0.09 0.01 –0.10 –0.70 –0.20 –0.04 \n12. Cinacalcet 0.22 0.15 –0.0.8 0.00 0.17 0.02 \n13. Arbidol –0.19 –0.44 –0.39 –0.34 –0.46 –0.07 \n14. Hydroxychloroquine 0.35 0.30 0.44 –0.12 0.12 0.15 \n15. Oberadilol 0.04 –0.47 –0.43 –0.37 –0.02 0.02 \n16. Poziotinib 0.04 –0.17 0.53 –0.35 –0.27 0.01 "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T795","span":{"begin":0,"end":2},"obj":"Sentence"},{"id":"T796","span":{"begin":3,"end":6},"obj":"Sentence"},{"id":"T797","span":{"begin":8,"end":48},"obj":"Sentence"},{"id":"T798","span":{"begin":49,"end":193},"obj":"Sentence"},{"id":"T799","span":{"begin":194,"end":219},"obj":"Sentence"},{"id":"T800","span":{"begin":220,"end":222},"obj":"Sentence"},{"id":"T801","span":{"begin":224,"end":276},"obj":"Sentence"},{"id":"T802","span":{"begin":277,"end":279},"obj":"Sentence"},{"id":"T803","span":{"begin":281,"end":334},"obj":"Sentence"},{"id":"T804","span":{"begin":335,"end":337},"obj":"Sentence"},{"id":"T805","span":{"begin":339,"end":392},"obj":"Sentence"},{"id":"T806","span":{"begin":393,"end":395},"obj":"Sentence"},{"id":"T807","span":{"begin":397,"end":450},"obj":"Sentence"},{"id":"T808","span":{"begin":451,"end":453},"obj":"Sentence"},{"id":"T809","span":{"begin":455,"end":509},"obj":"Sentence"},{"id":"T810","span":{"begin":510,"end":512},"obj":"Sentence"},{"id":"T811","span":{"begin":514,"end":563},"obj":"Sentence"},{"id":"T812","span":{"begin":564,"end":566},"obj":"Sentence"},{"id":"T813","span":{"begin":568,"end":624},"obj":"Sentence"},{"id":"T814","span":{"begin":625,"end":627},"obj":"Sentence"},{"id":"T815","span":{"begin":629,"end":681},"obj":"Sentence"},{"id":"T816","span":{"begin":682,"end":684},"obj":"Sentence"},{"id":"T817","span":{"begin":686,"end":742},"obj":"Sentence"},{"id":"T818","span":{"begin":743,"end":746},"obj":"Sentence"},{"id":"T819","span":{"begin":748,"end":795},"obj":"Sentence"},{"id":"T820","span":{"begin":796,"end":799},"obj":"Sentence"},{"id":"T821","span":{"begin":801,"end":857},"obj":"Sentence"},{"id":"T822","span":{"begin":858,"end":861},"obj":"Sentence"},{"id":"T823","span":{"begin":863,"end":914},"obj":"Sentence"},{"id":"T824","span":{"begin":915,"end":918},"obj":"Sentence"},{"id":"T825","span":{"begin":920,"end":972},"obj":"Sentence"},{"id":"T826","span":{"begin":973,"end":976},"obj":"Sentence"},{"id":"T827","span":{"begin":978,"end":1036},"obj":"Sentence"},{"id":"T828","span":{"begin":1037,"end":1040},"obj":"Sentence"},{"id":"T829","span":{"begin":1042,"end":1095},"obj":"Sentence"},{"id":"T830","span":{"begin":1096,"end":1099},"obj":"Sentence"},{"id":"T831","span":{"begin":1101,"end":1153},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"S. No. Ligands Parameters of bioactivity score\nGPCR ligand Ion channel modulator (ICM) Kinase inhibitor (KI) Nuclear receptor ligand (NRL) Protease inhibitor (PI) Enzymeinhibitor (EI) \n \n1. Withaferin A 0.07 0.14 –0.49 0.76 0.15 0.94 \n2. Withanolide A 0.04 0.32 –0.43 0.71 0.15 0.86 \n3. Withanolide B 0.07 0.24 –0.47 0.79 0.15 0.76 \n4. Withanolide D 0.05 0.30 –0.50 0.73 0.16 1.07 \n5. Withanolide E –0.70 0.16 –0.50 0.61 0.06 0.89 \n6. Withanone 0.00 0.27 –0.38 0.71 0.12 0.78 \n7. Viscosalactone B 0.03 0.04 –0.51 0.78 0.19 0.84 \n8. Anaferine –0.08 0.17 –0.60 –0.58 –0.14 0.08 \n9. Withasomnine –0.49 –0.43 0.58 –0.10 –0.58 –0.17 \n10. Losartan 1.06 0.16 0.03 0.01 0.33 0.44 \n11. Procainamide –0.09 0.01 –0.10 –0.70 –0.20 –0.04 \n12. Cinacalcet 0.22 0.15 –0.0.8 0.00 0.17 0.02 \n13. Arbidol –0.19 –0.44 –0.39 –0.34 –0.46 –0.07 \n14. Hydroxychloroquine 0.35 0.30 0.44 –0.12 0.12 0.15 \n15. Oberadilol 0.04 –0.47 –0.43 –0.37 –0.02 0.02 \n16. Poziotinib 0.04 –0.17 0.53 –0.35 –0.27 0.01 "}